EcoDrugPlus

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSLOCG00000009910
Gene Symbol: GRM4
3 Cross references
273 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSLOCG00000007164
Gene Symbol: GRM5
3 Cross references
284 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSLOCG00000009807
Gene Symbol: LOC102693889
3 Cross references
324 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSLOCG00000011974
Gene Symbol: GRIN2BB
1 Cross references
330 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 5

Ensembl ID : ENSLOCG00000004659
Gene Symbol: GRIK5
1 Cross references
303 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSLOCG00000010693
Gene Symbol: GRM2B
1 Cross references
276 Possible Orthologues:

Glutaminase

Ensembl ID : ENSLOCG00000009954
Gene Symbol: GLS
3 Cross references
305 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSLOCG00000007035
Gene Symbol: GSK3B
3 Cross references
241 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSLOCG00000008760
Gene Symbol: LOC102694185
3 Cross references
203 Possible Orthologues:

Granzyme B(G,h)-Like

Ensembl ID : ENSLOCG00000005312
Gene Symbol: LOC102687051
2 Cross references
884 Possible Orthologues:

Granzyme B(G,h)-Like

Ensembl ID : ENSLOCG00000005290
Gene Symbol: LOC102686851
2 Cross references
884 Possible Orthologues:

Granzyme B-Like

Ensembl ID : ENSLOCG00000005356
Gene Symbol: LOC102687250
2 Cross references
884 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).